Evaluation on Efficacy and Safety of Arsenic Trioxide Plus Transcatheter Arterial Chemoembolization Versus Transcatheter Arterial Chemoembolization alone for Unresectable Primary Liver Cancer

Currently, some clinical trials of arsenic trioxide (As203) plus transcatheter arterial chemoembolization (TACE) in the treatment of unresectable primary liver cancer (PLC) had been conducted, but the results were controversial. Therefore, we performed a meta-analysis on 14 clinical trials (1076 cas...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Asian Pac J Cancer Prev
Autores principales: Yang, Haitao, Zhou, Sijing, Shen, Ruifen, Luo, Shuimei, Li, Lina, Lin, Heng, Chen, Huijuan, Liao, Ziyuan, Lin, Wanzun, Xie, Xianhe
Formato: Artigo
Lenguaje:Inglês
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5747392/
https://ncbi.nlm.nih.gov/pubmed/29072394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2017.18.10.2695
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares